Cytotoxic drugs efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma

Experimental studies indicated that long-chain polyunsaturated fatty acids may increase sensitivity of mammary tumours to several cytotoxic drugs. To evaluate this hypothesis in breast cancer, we have prospectively studied the association between levels of fatty acids stored in breast adipose tissue and the response of the tumour to chemotherapy in 56 patients with an initially localized breast carcinoma. Adipose breast tissue was obtained at the time of biopsy, and individual fatty acids were measured as a percentage of total fatty acids using capillary gas chromatography. Patients then received primary chemotherapy, combining mitoxantrone, vindesine, cyclophosphamide and 5-fluorouracil every 4 weeks. Tumour size was reassessed after three cycles of chemotherapy. Tumour response was evaluated according to World Health Organization criteria. Complete or partial response to chemotherapy was achieved in 26 patients (47%). Level of n-3 polyunsaturated fatty acids in adipose tissue was higher in the group of patients with complete or partial response to chemotherapy than in patients with no response or with tumour progression (P < 0.004). Among n-3 polyunsaturated, only docosahexaenoic acid (22:6n-3) was significantly associated with tumour response (P < 0.005). In a logistic regression analysis taking into account age, body mass index and tumour size, 22:6 n-3 level proved to be an independent predictor for chemosensitivity (P = 0.03). These results suggest that, in breast cancer, 22:6 n-3 may increase the response of the tumour to the cytotoxic agents used. © 1999 Cancer Research Campaig

Treatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary- an experience in Taiwan

<p>Abstract</p> <p>Purpose</p> <p>The aim of this study was to evaluate treatment results in our hypopharyngeal cancer patients.</p> <p>Patients and Methods</p> <p>A total of three hundred and ninety five hypopharyngeal cancer patients received radical treatment at our hospital; 96% were male. The majority were habitual smokers (88%), alcohol drinkers (73%) and/or betel quid chewers (51%). All patients received a CT scan or MRI for tumor staging before treatment. The stage distribution was stage I: 2 (0.5%); stage II: 22 (5.6%); stage III: 57 (14.4%) and stage IV: 314 (79.5%). Radical surgery was used first in 81 patients (20.5%), and the remaining patients (79.5%) received organ preservation-intended treatment (OPIT). In the OPIT group, 46 patients received radiotherapy alone, 156 patients received chemotherapy followed by radiotherapy (CT/RT) and 112 patients received concomitant chemo-radiotherapy (CCRT).</p> <p>Results</p> <p>The five-year overall survival rates for stages I/II, III and IV were 49.5%, 47.4% and 18.6%, respectively. There was no significant difference in overall and disease-specific survival rates between patients who received radical surgery first and those who received OPIT. In the OPIT group, CCRT tended to preserve the larynx better (p = 0.088), with three-year larynx preservation rates of 44.8% for CCRT and 27.2% for CT/RT. Thirty-seven patients developed a second malignancy, with an annual incidence of 4.6%.</p> <p>Conclusions</p> <p>There was no survival difference between OPIT and radical surgery in hypopharyngeal cancer patients at our hospital. CCRT may offer better laryngeal preservation than RT alone or CT/RT. However, prospective studies are still needed to confirm this finding. Additionally, second primary cancers are another important issue for hypopharyngeal cancer management.</p

Effect of the silane concentration on the selected properties of an experimental microfilled composite resin

The aim of present study was evaluate the effect of different percentages of an organo-functionalized silane monomer as adhesion promoter between barium borosilicate glass fillers and (co)monomer blend in experimental dental composite resin. Gamma-methacryloxypropyltrimethoxysilane (γ-MPS) was assessed in an experimental luting cement, at the concentrations of 0, 1, 3, 5, 7 and 10 (wt%). The experimental resin without fillers was used as control group. The flexural strength (FS) and elastic modulus (E) were obtained by mini-flexural test and expressed in MPa and GPa, respectively. Water sorption (WS) and solubility (SL) were determined based on ISO standard 4049:2000. Kruskal–Wallis and Student–Newman–Keuls test were used for comparisons of FS, E and WS. The comparisons of SL means were performed using one-way ANOVA and Tukey's method (α = 5 %). The treatment with 3 % silane revealed statistically higher FS, while the group treated with 1 % silane showed statistically higher E than 3 % silane (p < 0.05) and E similar to control. The experimental composite without filler content showed the highest SL (p < 0.05) while the control composite showed the highest WS (p < 0.05). Based on present findings, flexural strength and elastic modulus can sometimes be improved with lower concentrations (1–3 %) rather than higher concentrations (5–7 %) of the silane (γ-MPS) used as coupling agent on barium borosilicate glass filler microparticles of the dental composite resin

Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).

Prostate-specific membrane antigen (PSMA) is expressed by the majority of clinically significant prostate adenocarcinomas, and patients with target-positive disease can easily be identified by PSMA PET imaging. Promising results with PSMA-targeted radiopharmaceutical therapy have already been obtained in early-phase studies using various combinations of targeting molecules and radiolabels. Definitive evidence of the safety and efficacy of [177Lu]Lu-PSMA-617 in combination with standard-of-care has been demonstrated in patients with metastatic castration-resistant prostate cancer, whose disease had progressed after or during at least one taxane regimen and at least one novel androgen-axis drug. Preliminary data suggest that 177Lu-PSMA-radioligand therapy (RLT) also has high potential in additional clinical situations. Hence, the radiopharmaceuticals [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&amp;T are currently being evaluated in ongoing phase 3 trials. The purpose of this guideline is to assist nuclear medicine personnel, to select patients with highest potential to benefit from 177Lu-PSMA-RLT, to perform the procedure in accordance with current best practice, and to prepare for possible side effects and their clinical management. We also provide expert advice, to identify those clinical situations which may justify the off-label use of [177Lu]Lu-PSMA-617 or other emerging ligands on an individual patient basis

Effect of different light-curing devices and aging procedures on composite knoop microhardness

The aim of this study was to evaluate the effect of light-curing devices (Halogen/HAL, Light Emitting Diodes/LED, Argon Laser/LAS and Plasma Arc/PAC) and aging procedures (Mechanical Cycling/MC, Thermal Cycling/TC, Storage/S, MC+TC and MC+TC+S) on the micro-hardness of bottom/B and top/T surfaces of 2-mm-high composite resin cylinders. The Knoop microhardness test (25 g, 20 s) on both B and T was performed before and after each aging procedure. For B and T, before aging procedures, PAC showed reduced polymerization effectiveness when compared with HAL. In the T, after TC, PAC and LAS had also showed reduced polymerization effectiveness when compared to HAL and LED. For all light-curing devices, MC+TC+S and S affected the Knoop microhardness values. In the B, no difference could be observed among the aging procedures for PAC. From all light-curing units, PAC may have rendered composites of reduced quality and the storage aging procedures were the most harmful to the polymer hardness

Effect of light-activation methods and water storage on the flexural strength of two composite resins and a compomer Efeito da fotoativação e da armazenagem em água na resistência à flexão de duas resinas compostas e um compômero

The present study evaluated the flexural strength of three composite resins recommended for direct esthetic restorations: a polyacid modified composite (Dyract AP), a unimodal composite resin (Filtek Z250) and a hybrid composite resin (Point 4). The variation factors, apart from the type of composite resin, were the light activation method and the water storage period. The composite resins were light-cured in continuous mode (40 s, 500 mW/cm²) or in ramp mode (0-800 mW/cm² for 10 s followed by 30 s at 800 mW/cm²) and stored for 24 hours or 30 days in distilled water at 37°C. The data were analyzed by ANOVA and Tukey test for multiple comparisons (alpha = 0.05). The composite resin Z250 presented the highest mean flexural strength (166.74 MPa) and Dyract AP presented the lowest one (129.76 MPa). The storage for 30 days decreased the flexural strength in ramp mode (24 h: 156.64 MPa; 30 days: 135.58 MPa). The light activation method alone did not lead to different flexural strength values.<br>O presente estudo analisou a resistência à flexão de três compósitos recomendados para restaurações estéticas diretas: um compósito poliácido-modificado (Dyract AP), uma resina composta unimodal (Filtek Z250) e uma resina composta híbrida (Point 4). Os fatores de variação, além do tipo de compósito, foram o método de fotoativação e o período de armazenagem em água. Os materiais foram fotoativados continuamente por 40 s (500 mW/cm²) ou com intensidade de luz crescente (0-800 mW/cm² por 10 s seguidos de 30 s a 800 mW/cm²). Os períodos de armazenagem foram de 24 horas ou 30 dias em água destilada a 37°C. Os dados foram submetidos à análise de variância e ao teste de Tukey para comparações múltiplas (alfa = 0,05). A resina composta Z250 apresentou a maior média de resistência à flexão (166,74 MPa) e a Dyract AP, a menor (129,76 MPa). A armazenagem por 30 dias diminuiu a resistência à flexão para o método de fotoativação crescente (24 h: 156,64 MPa; 30 dias: 135,58 MPa). O método de fotoativação isoladamente não conduziu a diferentes valores de resistência à flexão